ADVAIR HFA 115 ug/1 (Fluticasone Propionate and Salmeterol Xinafoate AEROSOL, METERED) 115 ug/1

ADVAIR HFA 115 ug/1 is a combination inhaler containing fluticasone propionate and salmeterol xinafoate. It is commonly used for managing asthma and chronic obstructive pulmonary disease (COPD). This metered aerosol is designed for respiratory administration.

Strength

115 ug/1

Pack Size

1 INHALER in 1 CARTON (0173-0716-22) / 60 AEROSOL, METERED in 1 INHALER

Manufacturer / TM Owner

GlaxoSmithKline LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ADVAIR HFA 115 ug/1 is primarily used for the maintenance treatment of asthma and to prevent bronchospasm in patients with COPD. The combination of fluticasone propionate and salmeterol xinafoate works to reduce inflammation and relax the muscles in the airways, making it easier to breathe. This inhaler is often prescribed for long-term management rather than for immediate relief of symptoms.

Side Effects

Common effects of using ADVAIR HFA 115 ug/1 may include a reduction in asthma symptoms such as wheezing, shortness of breath, and coughing. Some users may experience mild side effects like throat irritation, hoarseness, or a dry mouth. It is important to use the inhaler as directed by a healthcare provider to achieve the best results.

Precautions & Warnings

ADVAIR HFA 115 ug/1 should be used with caution, especially in individuals with a history of severe asthma attacks or other respiratory conditions. It is important to follow the prescribed dosage and administration instructions to minimize the risk of side effects. Always consult a healthcare provider before starting or stopping this medication.

Avoid Interactions

ADVAIR HFA 115 ug/1 may interact with other medications, including beta-blockers, diuretics, and certain antifungal or antibiotic drugs. It is also advisable to avoid using other inhalers unless directed by a healthcare provider. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

ADVAIR HFA 115 ug/1 is used for the maintenance treatment of asthma and to prevent bronchospasm in patients with COPD.

ADVAIR HFA 115 ug/1 is designed for respiratory administration. Follow the instructions provided by your healthcare provider for proper use.

Common side effects may include throat irritation, hoarseness, and a dry mouth. Always consult a healthcare provider for personalized advice.

ADVAIR HFA 115 ug/1 may interact with other medications. Consult your healthcare provider before combining it with other treatments.

ADVAIR HFA 115 ug/1 is designed for long-term management rather than immediate relief. Use a rescue inhaler for sudden symptoms.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.